BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24418258)

  • 21. Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms.
    Bao C; Bajrami B; Marcotte DJ; Chodaparambil JV; Kerns HM; Henderson J; Wei R; Gao B; Dillon GM
    Cell Mol Neurobiol; 2021 May; 41(4):669-685. PubMed ID: 32424773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
    García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
    Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of tauopathies with transgenic mice.
    Hutton M; Lewis J; Dickson D; Yen SH; McGowan E
    Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.
    Lim J; Balastik M; Lee TH; Nakamura K; Liou YC; Sun A; Finn G; Pastorino L; Lee VM; Lu KP
    J Clin Invest; 2008 May; 118(5):1877-89. PubMed ID: 18431510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43.
    Liachko NF; McMillan PJ; Strovas TJ; Loomis E; Greenup L; Murrell JR; Ghetti B; Raskind MA; Montine TJ; Bird TD; Leverenz JB; Kraemer BC
    PLoS Genet; 2014 Dec; 10(12):e1004803. PubMed ID: 25473830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.
    Britschgi M; Takeda-Uchimura Y; Rockenstein E; Johns H; Masliah E; Wyss-Coray T
    J Neuroinflammation; 2012 Sep; 9():220. PubMed ID: 22989354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in MAPT give rise to aneuploidy in animal models of tauopathy.
    Rossi G; Conconi D; Panzeri E; Paoletta L; Piccoli E; Ferretti MG; Mangieri M; Ruggerone M; Dalprà L; Tagliavini F
    Neurogenetics; 2014 Mar; 15(1):31-40. PubMed ID: 24218087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation.
    Sato S; Cerny RL; Buescher JL; Ikezu T
    J Neurochem; 2006 Sep; 98(5):1573-84. PubMed ID: 16923168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
    Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau-tubulin kinase 1 expression, phosphorylation and co-localization with phospho-Ser422 tau in the Alzheimer's disease brain.
    Lund H; Cowburn RF; Gustafsson E; Strömberg K; Svensson A; Dahllund L; Malinowsky D; Sunnemark D
    Brain Pathol; 2013 Jul; 23(4):378-89. PubMed ID: 23088643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a
    Bukhari H; Nithianandam V; Battaglia RA; Cicalo A; Sarkar S; Comjean A; Hu Y; Leventhal MJ; Dong X; Feany MB
    Genome Res; 2024 May; 34(4):590-605. PubMed ID: 38599684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel calcium-binding protein is associated with tau proteins in tauopathy.
    Vega IE; Traverso EE; Ferrer-Acosta Y; Matos E; Colon M; Gonzalez J; Dickson D; Hutton M; Lewis J; Yen SH
    J Neurochem; 2008 Jul; 106(1):96-106. PubMed ID: 18346207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
    J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
    Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
    J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration.
    De Jesús-Cortés HJ; Nogueras-Ortiz CJ; Gearing M; Arnold SE; Vega IE
    Neuroreport; 2012 Nov; 23(16):942-6. PubMed ID: 22975846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytic neuroprotection through induction of cytoprotective molecules; a proteomic analysis of mutant P301S tau-transgenic mouse.
    Yata K; Oikawa S; Sasaki R; Shindo A; Yang R; Murata M; Kanamaru K; Tomimoto H
    Brain Res; 2011 Sep; 1410():12-23. PubMed ID: 21803337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
    Bhaskar K; Hobbs GA; Yen SH; Lee G
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):462-77. PubMed ID: 20609109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.